ZGZahra Goodarzi

Zahra Goodarzi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zahra Goodarzi has a total of 176 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mild behavioral impairment-apathy and Alzheimer's disease plasma phosphorylated tau biomarker levels

    by Daniella Vellone, Rebeca Leon, Zahra Goodarzi, Nils D. Forkert, Eric E. Smith, Zahinoor Ismail

    Background: Mild behavioral impairment (MBI), characterized by later-life emergence of persistent neuropsychiatric symptoms (NPS), is an early clinical indicator of dementia risk. Global MBI has been associated with Alzheimer's disease (AD) pathology; studies have also explored MBI domains. Prior work has linked MBI-apathy to AD cerebrospinal fluid (CSF) biomarkers, but whether associations are detectable using plasma-based biomarkers such as phosphorylated tau (p-tau) is unknown. Establishing such relationships is critical, as plasma biomarkers are more accessible than CSF. Objective: To explore cross-sectional and longitudinal associations between MBI-apathy and plasma p-tau 181 levels using Alzheimer's Disease Neuroimaging Initiative data. Methods: Older adults with normal cognition or mild cognitive impairment were categorized as MBI-apathy (n = 69), non-MBI NPS (n = 112), and no-NPS (n = 215) based on Neuropsychiatric Inventory scores and symptom persistence over one year. Linear regression modelled cross-sectional associations between NPS group and plasma p-tau 181 , adjusting for age, sex, education, apolipoprotein E4 status, and Mini-Mental State Examination score. Hierarchical linear mixed-effects modelling assessed associations over two and three years, including time-by-NPS group interactions. Results: MBI-apathy was associated with significantly higher plasma p-tau 181 levels at baseline (24.05% [6.06–45.08%]; adjusted p = 0.014), and over two (26.46% [7.24–49.12%]; adjusted p = 0.012) and three years (29.28% [10.17–51.72%]; adjusted p = 0.004) compared to no-NPS. No significant associations were observed for non-MBI NPS. In sensitivity analyses, non-MBI apathy was not associated with plasma p-tau 181 at baseline (−9.96% [−32.69–20.44%]; unadjusted p = 0.478). Conclusions: MBI-apathy is associated with elevated plasma p-tau 181 cross-sectionally and longitudinally, supporting MBI-apathy as a potential proxy marker of tau pathology for early AD detection.

  • Open Access

    Indigenization, Personalization, and Intersections: A Qualitative Study to Identify Essential Components for Developing an Indigenous-Centered Dementia Care Model in Alberta

    by Jaiden Kuchinka, Richard T. Oster, Zahra Goodarzi, Zack Marshall, Lynn Jackson, Jayna Holroyd-Leduc, Vivian Ewa, Lisa Bourque Bearskin, Dallas Seitz, Jennifer D. Walker, et al.

    Current models of dementia care often perpetuate the legacies of colonization, which highlights the need for a culturally congruent approach. This research describes the necessary components to co-develop a freely available Indigenous-centered dementia model of care in partnership with Indigenous individuals living with dementia, their families, and communities. To prioritize ethical and decolonial research approaches, sequential focus groups were used alongside Keeoukaywin (The Visiting Way)—an Indigenous methodology deeply rooted in Métis and Cree ways of knowing—guided by a group of advisors and Elders. The data were co-analyzed using reflexive thematic analysis guided by Indigenous principles. Three themes were generated: Indigenization, Personalization, and the Intersection of Challenges and Innovations, to illustrate how dementia care can be operationalized and adapted to various cultural and care contexts. This research offers a foundation for developing dementia care that truly aligns with Indigenous ways of doing.

  • Open Access

    Ensuring Clinical Practice Guidelines Meet the Needs of the End-User: a Prioritization Survey for Guideline Topics for Behavioural and Psychological Symptoms of Dementia

    by Kayla Atchison, Jennifer A. Watt, Jennifer Porter, Dallas Seitz, Julia Kirkham, Zahra Goodarzi

    Background Behavioural and psychological symptoms of dementia (BPSD) are complex to assess and manage, and a lack of updated clinical practice guidelines (CPGs) leads to variation in clinical practice. When generating CPGs, involvement of end-users in developing and prioritizing topics is key to creating effective recommendations. Methods To inform the creation of a CPG for the management of BPSD, we completed a Canada-wide online BPSD topic prioritization survey using Qualtrics. In January-March 2023 the survey was disseminated widely to identify preferred terminology to use in the guideline and to prioritize topics to be included. Results Two hundred fifty-four persons responded to the survey. Participants were mostly female (88.2%), identified as women (87.0%), were aged 50-64 (37.0%), from Ontario (69.7%), and from nursing roles (n=83). BPSD was the most preferred terminology (32.1%) followed by responsive behaviours (26.2%). Seven topics were reviewed for guideline inclusion, with priority placed on prevention, non-drug management, and prodromal symptoms. Comments from participants identified concerns around validity of detection tools, possible lack of available evidence, and conflict between standardized approaches versus the need for individualized care. Conclusions Involvement of end-users in the determination of terminology and prioritization of topics was an effectual way to ensure CPGs represent the needs of the user.

  • Open Access

    Paramedic Perspectives on Managing Agitation in Older Adults: A Descriptive Mixed-Methods Cross-Sectional Survey in Alberta, Canada

    by Fatima I. Shah, Ryan Lee, Krista Reich, Kathryn Crowder, Stephanie VandenBerg, Rebecca Schonnop, Zahinoor Ismail, Eddy Lang, Jayna Holroyd-Leduc, Jacques S. Lee, et al.

  • Open Access

    Diagnostic Accuracy of Tools to Identify Anxiety Symptoms and Disorders in Persons with Dementia: a Systematic Review Update

    by Kayla Atchison, Pauline Wu, Dallas Seitz, Jennifer A. Watt, Zahra Goodarzi

    Limited anxiety tools validated against a diagnostic gold standard in the context of dementia have been identified. A systematic review update was completed to identify publica-tions since 2017 describing tools to detect anxiety in persons with dementia compared to a diagnostic gold standard. The original search strategy was replicated in MEDLINE, Embase, and PsycINFO. Pooled prevalence and diagnostic accuracy estimates were calculated based on three or more studies presenting comparable information from either the original or updated review search. No pooled estimates were calculated in the original review given limited evidence. One study evaluating the Rating Anxiety in Dementia (RAID) scale, Neuropsychiatric Inventory, and Hamilton Anxiety Rating Scale met review inclusion criteria. The pooled prevalence of generalized anxiety disorder (GAD) (n=3, 36.7%, 95% Confidence Interval (CI): 24.3–49.2%) and diagnostic accuracy outcomes for the RAID scale ( ≥11 cut-off) to detect GAD (n=3, sensitivity: 89%, 95% CI: 78–95%; specificity: 73%, 95% CI: 60–82%) were calculated using data from two studies identified in the original review and the newly included study from the review update. The RAID scale has the most evidence and adequate sensitivity to support its use in identifying anxiety in persons with dementia. Validated tools to detect anxiety in persons with dementia remain understudied.

  • Open Access

    Management of Agitation in Emergency Medical Services for Older Adults: A Qualitative Exploration

    by Fatima I. Shah, Grace Lew, Ryan Lee, Krista Reich, Kathryn Crowder, Stephanie VandenBerg, Margaret McGillivray, Ian E. Blanchard, Zahra Goodarzi

    Introduction: Emergency medical services (EMS) providers are often first responders to agitated older adults, providing critical clinical care and transport. However, significant knowledge gaps persist in our understanding of agitation management for older adults in the prehospital setting. Aims: To describe the barriers and facilitators to the management of agitation in older adults and the reduction of restraint use by EMS providers. Methods: In‐depth semi‐structured qualitative interviews ( n = 30) took place with EMS providers employed in Alberta, Canada. The theoretical domains framework (TDF) served as a guiding structure for the development of the interview guide. Framework analysis was used to analyze the qualitative data: a line‐by‐line thematic analysis was used to identify codes/themes, which were then mapped onto the TDF, and behavior change wheel. Results: Six major thematic categories were identified. EMS providers reported inadequate training and support, especially for managing agitation in older adult populations. Restraints are used as a safety measure for patient and provider safety, and as a last resort once other agitation management strategies have been exhausted. EMS providers report a complex decision‐making matrix of balancing the risks, benefits, and ethical considerations of restraint use, which is often collaborative and integrates EMS protocols. Common barriers to effective agitation management in EMS, as well as non‐restraint agitation management techniques are also discussed. Conclusion: The present study is the first in‐depth exploration of EMS provider experiences regarding the management of agitation and chemical and physical restraints in older adults.


  • Open Access

    Creating a Clinical Care Pathway for Depressive Symptoms and Disorders in Long-Term Care: A Modified Delphi Process

    by Kayla Atchison, Andrea Gruneir, Jason Sutherland, Eric E. Smith, Marie-Andree Bruneau, Zahinoor Ismail, Vivian Ewa, Loralee Fox, Carole A. Estabrooks, Jennifer A. Watt, et al.

  • Open Access

    Developing a Frailty Care Pathway for Older Adults in Long-Term Care: A Modified Delphi Process

    by Pauline Wu, Jayna Holroyd-Leduc, Sharon Kaasalainen, David B. Hogan, Aynharan Sinnarajah, Michelle Grinman, James Silvius, Jessica E. Simon, Ann Madeline Toohey, Jacqueline McMillan, et al.

    Objective: We developed a clinical care pathway for the detection and management of frailty for older adults living in long-term care (LTC) homes. Methods: We utilized a modified Delphi with residents of LTC homes experiencing frailty, their caregivers, and care providers. The pathway was created using existing literature and input from key LTC experts. Findings: Fifty-two panelists completed round one of the Delphi, and 55.8% of these respondents completed round two. Both rounds had high agreement and ratings. We added six new statements following analysis of round two, and 15 statements were modified/updated to reflect panelist feedback. The final pathway included 28 statements and promotes a resident-centered approach that highlights caregiver involvement and inter-professional teamwork to identify and manage frailty, as well as initiate palliative care earlier. Conclusion: Implementing this pathway will allow health care providers to adopt screening measures and adapt care to a resident’s frailty severity.

  • Open Access

    Perceptions of Frailty in Long-Term Care

    by Kayla Atchison, Pauline Wu, Ann M. Toohey, Daniel Gaetano, Jacqueline McMillan, Jenna Naylor, Sharon Kaasalainen, Michelle N. Grinman, Vivian Ewa, Jessica Simon, et al.

    Background An early palliative approach to care may best suit the care needs of older persons with frailty living in long-term care (LTC). The study objective was to evaluate the barriers and facilitators to care for frailty in the LTC setting. Methods Semi-structured interviews were completed with physicians, nurse practitioners, registered nurses, allied health-care providers, care partners, and residents with care experience in LTC. Framework analysis methods that leveraged behaviour change theories were used to analyze the interview data and produce practice-oriented findings. Results Twenty-eight interviews were completed. Seven themes were identified: resident characteristics related to frailty; frailty detection and diagnosis; frailty treatment and care planning; frailty and prognosis conversations; palliative and end-of-life care; communication amongst LTC collaborators; and the LTC environment. All codes were labelled as barriers or facilita-tors and assigned to a primary domain within the Theoretical Domains Framework. Conclusions The lack of clinical recognition of frailty in the LTC setting was a key barrier to clinical pathway implementation. There is a need for frailty to be linked to prognosis and care decisions, for frailty to be directly addressed through individualized treatments, and for an early palliative approach to care to be accessible to residents. Identifying barriers to care for frailty is a critical step toward clinical care pathway implementation which may improve care and outcomes for residents of LTC.

  • Open Access

    Mild behavioural impairment-apathy and core Alzheimer's disease cerebrospinal fluid biomarkers

    by Daniella Vellone, Rebeca Leon, Zahra Goodarzi, Nils D Forkert, Eric E Smith, Zahinoor Ismail

    Apathy is a common neuropsychiatric symptom (NPS) in Alzheimer's disease (AD) but can emerge earlier in prodromal and even preclinical stages as part of mild behavioural impairment (MBI-apathy), a syndrome defined by emergent and persistent NPS. In dementia, apathy is associated with higher morbidity, mortality and caregiver distress. However, the significance of MBI-apathy in dementia-free persons, including its associations with AD biomarkers, remains unclear. This study aimed to determine whether MBI-apathy is associated with biomarker evidence of amyloid-beta (Aβ) and tau [phosphorylated (p-tau) and total (t-tau)] in CSF. Because MBI predicts incident dementia better than NPS without MBI, we aimed to determine the association between apathy and AD biomarkers when it occurred as part of the MBI syndrome and when it did not. Dementia-free participants with mild cognitive impairment or normal cognition from the Alzheimer's Disease Neuroimaging Initiative were stratified by NPS status (MBI-apathy, non-apathy MBI, non-MBI NPS and no-NPS) based on the Neuropsychiatric Inventory (NPI) or NPI-Questionnaire (NPI-Q). Linear regressions modelled cross-sectional associations between NPS status (predictor) and CSF biomarker ratios (Aβ42/Aβ40, p-tau181/Aβ42 and t-tau/Aβ42; primary outcomes) and levels (Aβ40, Aβ42, p-tau181 and t-tau; exploratory outcomes), adjusting for age, sex, apolipoprotein E4, education, Mini-Mental State Examination and NPI version. Hierarchical linear mixed-effects (LME) models assessed longitudinal associations over 2 years, incorporating random intercepts and slopes to account for repeated measures. Fixed effects included NPS status, all covariates from the linear regression model, and an interaction term between NPS status and time. Among 477 participants (176 cognitively normal), 52 had MBI-apathy. Primary cross-sectional analyses showed that, compared with the no-NPS group, MBI-apathy was associated with higher CSF p-tau181/Aβ42 [11.25% (2.56%–20.68%); adjusted P = 0.018] and t-tau181/Aβ42 [10.26% (2.42%–18.70%); adjusted P = 0.018]. Exploratory analyses revealed that MBI-apathy was associated with higher CSF p-tau181 [5.98% (0.50%–11.77%); P = 0.032]. Primary LME models showed that MBI-apathy was associated with higher CSF p-tau181/Aβ42 [11.34% (2.55%–20.88%); adjusted P = 0.022] and t-tau181/Aβ42 [10.34% (2.41–18.88%); adjusted P = 0.022] over 2 years. Exploratory LME models revealed that MBI-apathy was associated with higher CSF p-tau181 [6.03% (0.56%–11.81%); P = 0.032] and t-tau [4.96% (0.07%–10.09%); P = 0.049] over 2 years. MBI-apathy was significantly associated with core AD biomarkers cross-sectionally and longitudinally, over 2 years, underscoring its relevance as a marker of AD pathological burden. An overall MBI composite score might reflect a broader spectrum of pathology and warrants further investigation.